Tag: Acquisition

Tortoise Acquisition Corp. Announces Approval of Business Combination and Adjourns Special Meeting of Stockholders to September 30, 2020

NEW YORK–(BUSINESS WIRE)–Tortoise Acquisition Corp. (NYSE: SHLL) (“TortoiseCorp”) today announced that its stockholders voted to approve the proposed business combination between TortoiseCorp and Hyliion Inc. (“Hyliion”) and certain related proposals and that it has adjourned its virtual Special Meeting of Stockholders to September 30, 2020 at 1:00 p.m., Eastern time (the “Special Meeting”) to provide its shareholders additional time to vote on one of the ancillary proposals described in TortoiseCorp’s definitive proxy statement, dated September 8, 2020 (the “Proxy Statement”). To attend the reconvened virtual meeting, please visit https://www.cstproxy.com/tortoiseacquisitioncorp/sm2020.

TortoiseCorp urges its stockholders who have not voted to do so as soon as possible. TortoiseCorp received overwhelming support from stockholders for the proposed business combination with Hyliion. A sufficient number of votes to approve the business combination were received and TortoiseCorp expects to close the transaction on Thursday, October 1, 2020. However, TortoiseCorp values the input of all

Read More

HPE Completes Acquisition of SD-WAN Leader Silver Peak

Combination creates comprehensive networking portfolio to accelerate customers’ edge-to-cloud transformation

Hewlett Packard Enterprise (NYSE: HPE) today announced it has completed the acquisition of Silver Peak, an SD-WAN (Software-Defined Wide Area Network) leader, in a transaction valued at $925 million. Silver Peak will become a part of Aruba, a Hewlett Packard Enterprise company. The acquisition will strengthen Aruba ESP (Edge Services Platform), helping to advance enterprise cloud transformation with a comprehensive edge-to-cloud networking solution covering all aspects of wired, wireless local area networking (LAN) and wide area networking (WAN).

“WAN transformation is a key component of HPE’s Intelligent Edge and edge-to-cloud vision and growth strategy,” said Antonio Neri, president and CEO of HPE. “Armed with a comprehensive SD-WAN portfolio with the addition of Silver Peak, we will accelerate the delivery of a true distributed cloud model and cloud experience for

Read More

Nova Leap Health Corp. Expands in South Central U.S. with the Acquisition of Arkansas Home Care Business


3 “Strong Buy” Stocks That Are Flirting With a Bottom

In the investing game, it’s not only about what you buy; it’s about when you buy it. One of the most common pieces of advice thrown around the Street, “buy low” is touted as a tried-and-true tactic.Sure, the strategy seems simple. Stock prices naturally fluctuate on the basis of several factors like earnings results and the macro environment, amongst others, with investors trying to time the market and determine when stocks have hit a bottom. In practice, however, executing on this strategy is no easy task.On top of this, given the volatility that has ruled the markets over the last few weeks, how are investors supposed to gauge when a name is flirting with a bottom? That’s where the Wall Street pros come in.These expert stock pickers have identified three compelling tickers whose current share prices land close to

Read More

TriSalus Life Sciences Lays Out Therapeutic Strategy Upon Acquisition of First Therapeutic Candidate

DENVER & CHICAGO–(BUSINESS WIRE)–TriSalus Life Sciences (TriSalus), an emerging immuno-oncology company committed to transforming outcomes for patients with solid tumors, announced today its therapeutic clinical development strategy following the successful acquisition of SD-101, an investigational IND-ready immunotherapy, from Dynavax Technologies on August 3, 2020.

SD-101 is an investigational toll-like receptor 9 (TLR9) agonist that has been tested in Phase 2 clinical trials for advanced cutaneous melanoma and head and neck cancer, evaluating efficacy, safety, and the ability to increase responsiveness to checkpoint inhibitors in PD-L1 negative tumors. By combining SD-101 with TriSalus’ proprietary FDA cleared, drug delivery technologies, TriSalus will deliver the agent into the local vasculature of solid tumors. The Company intends to begin evaluating SD-101 in patients with uveal melanoma liver metastases followed by testing in patients with pancreatic ductal adenocarcinoma and colorectal cancer liver metastases. In addition, a separate program for locally advanced pancreatic ductal

Read More

Yucaipa Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing September 24, 2020

LOS ANGELES–(BUSINESS WIRE)–Yucaipa Acquisition Corporation (NYSE: YAC.U) (the “Company”) announced today that, commencing September 24, 2020, holders of the units sold in the Company’s initial public offering of 34,500,000 units, completed on August 6, 2020, may elect to separately trade the Class A ordinary shares and warrants included in the units. Those units not separated will continue to trade on the New York Stock Exchange (“NYSE”) under the symbol “YAC.U,” and the Class A ordinary shares and warrants that are separated will trade on the NYSE under the symbols “YAC” and “YAC WS,” respectively. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into Class A ordinary shares and warrants.

The units were initially offered by the Company in an underwritten offering. Citigroup Global Markets Inc. acted as the sole book-running

Read More

Tortoise Acquisition Corp. Reminds Stockholders to Vote in Favor of Business Combination with Hyliion Inc.

Tortoise Acquisition Corp. (NYSE: SHLL) (“TortoiseCorp”) reminds stockholders to vote in favor of the proposed business combination between TortoiseCorp and Hyliion Inc. (“Hyliion”), and the related proposals, to be voted upon at TortoiseCorp’s Special Meeting of Stockholders scheduled to be held virtually on Monday, September 28, 2020, at 9:30 am Eastern time (the “Special Meeting”), as described in TortoiseCorp’s definitive proxy statement, dated September 8, 2020 (the “Proxy Statement”).

Every stockholder’s vote is important, regardless of the number of shares the stockholder holds. Accordingly, TortoiseCorp requests that each stockholder complete, sign, date and return a proxy card, if it has not already done so, to ensure that such stockholder’s shares will be represented at the Special Meeting. Stockholders which hold shares in “street name,” meaning that their shares are held of record by a broker, bank or other nominee, should contact their broker, bank or nominee to ensure that their

Read More

Elder Scrolls Online Will Still Be Supported On PS4 After Microsoft Acquisition Of Bethesda

Microsoft’s acquisition this week of ZeniMax Media, the parent company of Bethesda, has brought with it ownership of several video game franchises. Included in that deal is The Elder Scrolls, a collection of games that includes the fifth chapter in the series, Skyrim, and its upcoming sequel.

In addition to those acquisitions there is also The Elder Scrolls Online, a massively multiplayer online role-playing game which began in 2014. Available on Xbox One, PC, and PlayStation 4, it’ll be business as usual for The Elder Scrolls Online even after Microsoft’s $7.5 billion purchase of it and the rest of the Bethesda game library.

“I want to take this moment to reassure the entire Elder Scrolls community that ESO will continue to be supported exactly as it was, and we fully expect to keep growing and thriving on each of the platforms that are currently supported,” Matt Firor, Studio Director of

Read More

Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities

SHANGHAI, Sept. 20, 2020 /PRNewswire/ — Viva Biotech (Shanghai) Co., Ltd. (hereinafter referred to as “Viva Biotech” or “The Company”) entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to acquire and the Vendors agreed to collectively sell 100% of the equity interest in SYNthesis med chem (Hong Kong) Limited (hereinafter referred to as ” SYNthesis “), at the consideration of approximately US$ 80 million (equivalent to approximately HK$ 620 million). The acquisition will achieve the synergies between Viva Biotech and SYNthesis, regarding to the CRO business in the global market, which is of great strategic significance for The Company to conduct vertical integration and establish a comprehensive one-stop drug services platform.

SYNthesis is a preclinical small molecule drug discovery service contract organisation which mainly provides high-end pharmaceutical chemistry and synthetic chemistry services to its clients. SYNthesis is headquartered in Hong

Read More

Hypur, A Cannabis Payments Company, Ditches Plaid After Visa Acquisition

Financial services company Plaid, known for powering account verification for some of the world’s biggest financial apps like Venmo and Robinhood, was recently acquired by Visa Inc (NYSE: V).

Considering Visa currently does not allow cannabis payments processing, cannabis-focused digital payments company Hypur announced Thursday it’s moving its account verification processes away from Plaid. The company will be verifying accounts in-house, via open banking, explained chief revenue officer Tyler Beuerlein. The aim is to ensure consumers and businesses can continue to operate as usual. 

With Hypur’s new open banking technology, consumers can easily and securely link their bank account to the Hypur app. Upgrading to open banking will allow the company to increase account security, while partnering with 17% more financial institutions than it currently operates with.

“Hypur has worked with the cannabis industry for over six years, supporting the cannabis community. We decided to upgrade our account verification to

Read More

Stepan Completes Acquisition of Surfactant Business and Sulfate Production Equipment in Mexico from Clariant

NORTHFIELD, Ill., Sept. 17, 2020 /PRNewswire/ — Stepan Company (NYSE: SCL) today reported that, through subsidiaries in Mexico, it has closed on an agreement with Clariant (Mexico) S.A. de C.V. to acquire Clariant’s anionic surfactant business and associated sulfation equipment located in Santa Clara, Mexico.  Financial terms of the transaction were not disclosed.

“This acquisition supports Stepan’s growth strategy in Latin America and enhances our ability to support our customers’ growth in the Mexican Consumer and Functional markets for surfactants,” said F. Quinn Stepan, Jr., Chairman, President and Chief Executive Officer of Stepan. “We look forward to transitioning customers’ supply to Stepan’s Ecatepec and Matamoros Mexico facilities over the coming months.”

Corporate Profile

Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients

Read More